Unidade Local de Saúde do Alto Minho   Report issue

Academic/Hospital Phase 2
Founded: Portugal (2008)

Organization Overview

First Clinical Trial
2020
NCT04251832
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Soraia Azevedo | Unidade Local de Saúde do Alto Minho

Active Ingredients

Drugs in Phase 2 Trials (1)

sodium thiosulfate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Shoulder Pain (Phase 2)

Tendinopathy (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1